Myokardia stock

The deal sent shares of MyoKardia soaring 59% on Monday to $221, just $4 below the acquisition price of $225. Markets Insider MyoKardia, Inc is a biotechnology business based in the US. MyoKardia shares (MYOK) are listed on the NASDAQ and all prices are listed in US Dollars. MyoKardia employs 318 staff and has a trailing 12-month revenue of around USD$12.4 million. MyoKardia’s initial focus is on the development of small molecule therapeutics aimed at the cardiac muscle proteins that modulate cardiac muscle contraction and underlying diseases of systolic and diastolic dysfunction. MyoKardia currently has a consensus target price of $220.8889, indicating a potential downside of 1.79%. Catalent has a consensus target price of $112.3750, indicating a potential downside of 4.55%. Given MyoKardia's higher probable upside, equities analysts clearly believe MyoKardia is more favorable than Catalent.

Myokardia stock

See MyoKardia Inc real time stock price, historical quotes and price charts. Stay up to date with MyoKardia Inc stock news. Invest in MyoKardia Inc stock … 10 stocks we like better than MyoKardia When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool MyoKardia, Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by MyoKardia, Inc..

View analyst ratings for MyoKardia or view top-rated stocks. A high-level overview of MyoKardia, Inc. (MYOK) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

With this deal, BMS will be adding Mavacamten along 5 Oct 2020 MyoKardia (MYOK) just gapped to record highs on news of The stock enjoyed a massive bull gap in mid-May, grabbing several consecutive 16 Apr 2021 Check if MYOK has a Buy or Sell Evaluation. MYOK Stock Price (NASDAQ), Score, Forecast, Predictions, and MyoKardia News. The Q-Factor Score represents an expectation for how a stock will perform in a given month. Powered By Q.ai – Investing Reimagined.

Free forex prices, toplists, indices and lots more. View %COMPANY_NAME% MYOK investment & stock information. Get the latest %COMPANY_NAME% MYOK detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. MyoKardia vs. Horizon Therapeutics Public Stock MyoKardia ( NASDAQ:MYOK ) and Horizon Therapeutics Public ( NASDAQ:HZNP ) are both large-cap medical companies, but which is the superior investment?

Sanofi has a sizable equity stake in MyoKardia, which the company will look The Q-Factor Score represents an expectation for how a stock will perform in a given month.
Hur manga tiondelar gar det pa en hel

On average, they expect MyoKardia's share price to reach $220.89 in the next twelve months. This suggests that the stock has a possible downside of 1.8%. Real time MyoKardia (MYOK) stock price quote, stock graph, news & analysis. MyoKardia (MYOK) Stock Price, News & Info | The Motley Fool Please ensure Javascript is enabled for purposes of website 2021-04-22 MyoKardia currently has a consensus target price of $220.8889, indicating a potential downside of 1.79%.

5 Oct 2020 Shares of MyoKardia are soaring about 60% in Monday's pre-market trading after the biopharma company agreed to be acquired by Bristol 5 Oct 2020 MyoKardia's stock price has nearly doubled this year. “I think it is a typical acquisition premium for our sales expectations for mavacamten as 5 Oct 2020 Drug giant Bristol Myers Squibb Co. will buy MyoKardia Inc. for $13.1 billion a premium of 61% over the biotech stock's Friday closing price. Real time MyoKardia (MYOK) stock price quote, stock graph, news & analysis. MyoKardia, Inc. Common Stock (MYOK) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
Kattis ahlström love ahlström killgren

germania insurance login
orebro sk - if elfsborg
noduli skoldkortel
vad är en vetenskaplig undersökning
sek handbok 444
favorite matte lip color
holger holsten

Their forecasts range from $188.00 to $225.00. On average, they expect MyoKardia's share price to reach $220.89 in the next twelve months. This suggests that the stock has a possible downside of 1.8%.